MICE OVEREXPRESSING LATENT TGF-B1 ARE PROTECTED AGAINST BLEOMYCIN-INDUCED PULMONARY INFLAMMATION AND FIBROSIS BY TARGETING TH-17/NF-kappa B/SMAD PATHWAYS